346 related articles for article (PubMed ID: 14733756)
1. Potential impact of population-based colorectal cancer screening in Canada.
Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.
Lejeune C; Dancourt V; Arveux P; Bonithon-Kopp C; Faivre J
Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
5. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
6. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
7. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal cancer.
Hakama M; Hoff G; Kronborg O; Påhlman L
Acta Oncol; 2005; 44(5):425-39. PubMed ID: 16118076
[TBL] [Abstract][Full Text] [Related]
10. [Colorectal cancer screening: advice from the Health Council of the Netherlands].
van Veen W; Mali WP
Ned Tijdschr Geneeskd; 2009; 153():A1441. PubMed ID: 20003552
[TBL] [Abstract][Full Text] [Related]
11. [National colorectal carcinoma screening program deserves further study; a report from the Dutch Health Council].
van Veen WA
Ned Tijdschr Geneeskd; 2001 Aug; 145(34):1655-7. PubMed ID: 11552370
[TBL] [Abstract][Full Text] [Related]
12. [Arguments against implementing a population-based screening programme for colorectal cancer].
Bonneux L
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer screening in Canada: results of a national survey.
Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
[TBL] [Abstract][Full Text] [Related]
14. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.
Ladabaum U; Song K
Gastroenterology; 2005 Oct; 129(4):1151-62. PubMed ID: 16230069
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
[TBL] [Abstract][Full Text] [Related]
17. Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.
N Z Med J; 1999 Jan; 112(1080):4-6. PubMed ID: 10073156
[TBL] [Abstract][Full Text] [Related]
18. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
19. Screening of colorectal cancer.
Winawer SJ
Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
[TBL] [Abstract][Full Text] [Related]
20. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
Kronborg O; Jørgensen OD; Fenger C; Rasmussen M
Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
